The Therapeutic Area Lead is responsible for leading Neuroscience (NS) and Infectious Disease & Vaccine (IDV) Regional Core Strategy Teams (RCSTs) to ensure cross-functional US alignment on future landscape/unmet needs and target product profile (TPP) requirements to maximize NS & IDV compound value for key stakeholders.
They are also responsible for providing US input into Global NS and IDV Therapeutic Area/Disease Area Stronghold (TA/DAS) and compound strategies.
In addition to leading commercial assessments to inform go/no-go recommendations for Phase 2b/3 compound stage-gate decisions. Responsible for US launch readiness for NS & IDV compounds.
Also responsible for providing US input to shape global Business Development (BD) strategy, assuring alignment with NS and IDV Business Unit Leaders. Executes US NS and IDV BD Strategy considering Global DAS strategies and therapeutic area priorities. Works closely with the Global Commercial Strategy Organization and Janssen Business Development teams to identify and prioritize external opportunities and works closely with US NPBD Analytics leading the US commercial assessments. Cultivates cross company relationships for franchise support.
This includes collaborating with GCSO, JBD and JBI key stakeholders. Sits on both the NS and IDV US Leadership Teams.
They will build defendable business cases and drives organizational alignment and demonstrates learning agility.
Effectively works across operating companies to identify/pursue TA partnerships.
Drives recommendations through organization to garner support go/no go decisions.
- Strategic Thinking
- Masters complexity on multiple levels
- Exhibits organizational savvy
- Drives and executes innovative and creative solutions
- Strong analytic skills
- Customer and marketplace focus
- Ability to support decisions in ambiguous situations
- Strong problem solving skills
- Ability to drive decisions with limited authority
United States-New Jersey-Titusville-
Janssen Pharmaceuticals, Inc. (6062)